Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
C. Diff Screening at Admission Can Cut Hospital- Acquired Infection
...
Already a member? Log in here
FDA Approves First Molecular Test of Antibiotic Resistance Directly From Patient Samples
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration (FDA) recently approved the first rapid molecular test for detection of antibiotic resistance directly from…
CDC Expands MicrobeNet Pathogen Library With Help From Industry
From - Diagnostic Testing & Emerging Technologies
The U.S. Centers for Disease Control and Prevention (CDC) recently announced another new partnership with industry to expand the utility of…
Genetic Test Registry Finds Growth of Oncology, NGS-Based Tests
From - Diagnostic Testing & Emerging Technologies
The number of cancer gene tests has grown tremendously in the past two years, particularly in the field of oncology where the number of tests grew by…
USPSTF Updates Colorectal Cancer Screening Guidelines to Include Molecular Test
From - Diagnostic Testing & Emerging Technologies
The U.S. Preventive Services Task Force (USPSTF) added molecular colorectal cancer (CRC) screening to its newly updated guidelines, but stopped short of…
Biden Launches Genomic Data Commons to Aid Sharing in Oncology
From - Diagnostic Testing & Emerging Technologies
Genomic Data Commons (GDC) launched this week as a core component of the National Cancer Moonshot and the President's Precision Medicine Initiative to promote data sharing between cancer researchers and accelerate the pace of…
Can Colorectal Screening Incorporate Adherence into Guidelines?
...
Already a member? Log in here
Is HCV Birth Cohort Testing Broad Enough?
...
Already a member? Log in here
Large Panels Complicate Results Reporting for Breast Cancer Risk
...
Already a member? Log in here